Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESTRO 2022 | Unmet needs in radiomics

Dirk De Ruysscher • 20 May 2022
ESTRO 2022
General

Dirk De Ruysscher, MD, PhD, Maastricht University Medical Center, Maastricht, Netherlands, and University of Leuven, Leuven, Belgium, discusses the main areas of unmet need in the field of radiomics and emphasises the importance of standardising and implementing radiomics into clinical practice. This interview took place at the European Society for Radiotherapy and Oncology (ESTRO) 2022 annual congress in Copenhagen, Denmark, and online.

More from Dirk De Ruysscher

2:01
How could radiomics improve oncology care in the future?
Dirk De Ruysscher • 20 May 2022
1:25
What is radiomics?
Dirk De Ruysscher • 20 May 2022
7:22
Early updates from the CheckMate73L study: nivo + CCRT followed by nivo + ipi in NSCLC
Dirk De Ruysscher • 6 Oct 2021
6:46
Radiomics in oncology
Dirk De Ruysscher • 6 Oct 2021

Related Videos

1:56
Phase I trial of trastuzumab deruxtecan and neratinib in HER2-altered tumors
Haeseong Park • 8 Apr 2024
2:45
Remaining challenges in treating solid tumors with CAR-Treg therapy
Leonardo Ferreira • 8 Apr 2024
2:01
Engineering chimeric antigen receptor regulatory T cells for treating cancer
Leonardo Ferreira • 8 Apr 2024
0:59
What challenges are there in using CAR-T cells for solid tumors?
Leonardo Ferreira • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals